食品科学 ›› 2025, Vol. 46 ›› Issue (15): 393-424.doi: 10.7506/spkx1002-6630-20250103-020

• 专题论述 • 上一篇    下一篇

人参皂苷对2型糖尿病肝脏病变的改善作用和机制

赵子琪,张芊伊,徐娇,郭晓晖   

  1. (1.中国农业大学食品科学与营养工程学院,北京 100083;2.国家食品安全风险评估中心,北京 100022)
  • 出版日期:2025-08-15 发布日期:2025-07-22
  • 基金资助:
    北京市自然科学基金面上项目(6222023);山东省重点研发计划项目(2024TSGC0072)

Alleviating Effect and Mechanism of Ginsenosides on Type 2 Diabetic Liver Lesions

ZHAO Ziqi, ZHANG Qianyi, XU Jiao, GUO Xiaohui   

  1. (1. College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China; 2. China National Center for Food Safety Risk Assessment, Beijing 100022, China)
  • Online:2025-08-15 Published:2025-07-22

摘要: 2型糖尿病是一种以慢性高血糖和胰岛素相对不足为特征的代谢性疾病。随着病程的进展,2型糖尿病患者肝脏常出现炎性水肿、脂肪变性及肝纤维化等病理变化,严重时可发展为肝硬化乃至肝癌。人参皂苷作为人参类植物的主要生物活性成分,在改善2型糖尿病血糖紊乱和肝脏损伤方面展现出显著的药理效应。其作用机制主要涉及调控肝脏糖脂代谢,增强胰岛素敏感性,并通过减轻氧化应激反应和抑制炎症反应减少肝细胞凋亡,从而有效缓解肝脏损伤,促进肝脏功能恢复。本文对人参皂苷在改善2型糖尿病肝脏损伤方面的作用及其机制进行系统综述,并简要概述2型糖尿病肝脏病变的发病机制,旨在为人参皂苷降糖机制的深入研究和降糖护肝药物的研发提供理论依据和实践参考。

关键词: 人参皂苷;2型糖尿病;肝脏病变

Abstract: Type 2 diabetes is a metabolic disease characterized by chronic hyperglycemia and relative insulin deficiency. As the disease progresses, type 2 diabetes often develop pathological changes in the liver such as inflammatory edema, fatty degeneration and liver fibrosis, which can develop into cirrhosis and, in severe cases, even liver cancer. Ginsenosides, the major bioactive components of the ginseng plant, show significant pharmacological effects on alleviating type 2 diabetic blood glucose disorders and liver damage. Their mechanism of action is mainly by regulating liver glucose and lipid metabolism, improving insulin sensitivity, and reducing hepatocyte apoptosis through the alleviation oxidative stress and the inhibition of inflammatory responses, thereby effectively alleviating liver damage and promoting liver function recovery. This article provides a systematic review of the effects and mechanisms of ginsenosides on alleviating diabetic liver injury and briefly outlines the pathogenesis of type 2 diabetic liver lesions, with the aim to provide a theoretical basis and practical reference for further investigating the hypoglycemic mechanism of ginsenosides and developing hypoglycemic and hepatoprotective drugs.

Key words: ginsenosides; type 2 diabetes mellitus; liver lesions

中图分类号: